RHUMBLINE ADVISERS - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 82 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2021$224,000
+9.8%
37,363
-4.0%
0.00%
Q4 2020$204,000
+61.9%
38,913
+7.2%
0.00%
Q3 2020$126,000
-64.4%
36,313
-11.0%
0.00%
-100.0%
Q2 2020$354,000
+66.2%
40,807
+11.4%
0.00%
Q1 2020$213,000
-19.0%
36,644
+0.3%
0.00%
Q4 2019$263,000
+19.5%
36,544
+1.2%
0.00%
Q3 2019$220,000
-34.1%
36,101
+2.6%
0.00%
-100.0%
Q2 2019$334,000
+32.0%
35,175
+12.8%
0.00%
Q1 2019$253,000
-48.8%
31,192
+2.7%
0.00%
-100.0%
Q4 2018$494,00030,3720.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders